MedImmune Inc. preclinical data

In mice, a combination vaccine developed by MEDI and partner Pasteur Merieux Connaught prevented infection at all challenge doses of Borrelia burgdorferi bacteria. Low doses of the combination vaccine were more effective than higher doses of either single antigen, MEDI said. Data were presented at the conference on Lyme Borreliosis and other Emerging Tick-Borne Diseases in Munich. ...